Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study
BACKGROUND Field testing required to license the combined measles, mumps, and rubella (MMR) vaccine must take into account the current recommendation of the vaccine in Brazil: first dose at 12 months and second dose at 15 months of age in combination with a varicella vaccine. OBJECTIVES This stud...
Main Authors: | Eliane Matos dos Santos, Tatiana Guimarães Noronha, Isabelle Soares Alves, Robson Leite de Souza Cruz, Clara Lucy de Vasconcellos Ferroco, Ricardo Cristiano Brum, Patricia Mouta Nunes de Oliveira, Marilda Mendonça Siqueira, Mariza Cristina Lima, Francisco Luzio de Paula Ramos, Camila de Marco Bragagnolo, Luiz Antonio Bastos Camacho, Maria de Lourdes de Sousa Maia |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Oswaldo Cruz, Ministério da Saúde
2019-03-01
|
Series: | Memórias do Instituto Oswaldo Cruz. |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762019000100314&lng=en&tlng=en |
Similar Items
-
An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines
by: Santos Boaventura Antônio dos, et al.
Published: (2002-01-01) -
Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University
by: Maryam Keshavarz, et al.
Published: (2016-06-01) -
The Investigation of Seroprevalence of Measles, Rubella, Mumps, and Varicella in Medical Students
by: Şebnem ÇALIK, et al.
Published: (2017-06-01) -
Evaluation of Measles, Rubella, Mumps, Hepatitis B and Varicella Zoster Antibodies in Medical and Dental Students in Shiraz, Iran
by: Afagh Moattari, et al.
Published: (2014-04-01) -
Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir<sup>®</sup> in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)
by: I. V. Feldblium, et al.
Published: (2021-03-01)